On the company's website, there is now a film with the CEO's presentation before the company's general meeting on 27 May.
Due to Covid-19, the Annual General Meeting will be conducted only by postal ballot. This means that the shareholders in the Company do not have the right to attend the meeting, either in person or through a proxy. Instead, shareholders have the right to exercise their voting right by post by voting in accordance with the instructions in this notice.
On the company's website, https://pharmacolog.com/investor-relations/annual-general-meeting-in-pharmacolog-may-27-2021/, there is now a film with the CEO's presentation before the company's general meeting on 27 May.
For more information contact:
Mats Högberg, CEO
Email: mats.hogberg@pharmacolog.com
Phone: +46 70-546 50 21
About Pharmacolog AB
Pharmacolog is specialized in developing systems and solutions for more effective and safer use of intravenous drugs. The company’s first product, DrugLog®, enables a nurse or pharmacist to quickly and easily verify that an injectable drug has the right identity and concentration. Pharmacolog’s long-term vision is an individually optimized medication for each individual patient, considering all available parameters in the control and distribution of the drug. Further information regarding the company is available at http://www.pharmacolog.com. The company’s Certified Adviser is Mangold Fondkommission AB, which can be reached on telephone number +46 8-5030 15 50 or through CA@mangold.se.
Release